Breast and Cervical Cancer Stigma in Rwanda
- Sponsor
- Dana-Farber Cancer Institute
- Study ID
- NCT07663006
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Behavioral: RISE Intervention — BEHAVIORALComponents: Resilience skills building (psychoeducation), peer-to-peer support groups, exposure to survivors via video storytelling Target: Patients with breast cancer and their caregivers
- Behavioral: CHW Educational Intervention — BEHAVIORALComponents: Exposure to survivors (video storytelling), educational curriculum (presentation, booklet, video) Target: Community health workers
Study Details
This study aims to assess breast and cervical cancer stigma and pilot a multi-modal intervention to mitigate stigma among patients, caregivers, and community health workers in Rwanda. The elements include resilience training (patient), support group (caregivers), or exposure to survivors by video and in-person (patient, caregivers, and community health workers), and educational curriculum (community health workers).
Key Dates
- Start date
- Nov 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 1, 2027
- Completion
- Dec 1, 2029
Study Design
- Enrollment
- 1,116 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Patient and Caregiver Intervention (RISE)Patients with breast cancer and their caregivers will receive the RISE intervention, which includes resilience skills building (patients), peer-to-peer support groups (caregivers), and exposure to survivors through video storytelling (both).
- Experimental: Community Health Worker (CHW) InterventionCommunity health workers will receive exposure to survivors' components and an educational curriculum delivered via presentation, booklet, and video.
Primary Outcome Measure
Prevalence of Cancer Stigma [ Time Frame: Baseline ]
Central Contacts
- Temidayo Fadelu, MD+1 617-632-3779
Related Studies
- Specimen and Data Study for Ovarian Cancer Early Detection and PreventionRecruiting · Northwestern University · Chicago, Illinois
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast CancerRecruiting · Carol Fabian, MD · Kansas City, Kansas